Company: LENZ
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001815776-25-000019
Chunk: 200

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 12
Chunk 200
---
 exercisable within 60 days of March 12, 2025.

(15)Consists of shares of Common Stock subject to options held by Ms. Drapkin exercisable within 60 days of March 12, 2025.

(16)Consists of (i) 775,919 shares of Common Stock beneficially owned by our executive officers and directors, (ii) 1,093,752 shares of Common Stock subject to options held our executive officers and directors and exercisable within 60 days of March 12, 2025, and (iii) 6,575 shares of Common Stock subject to warrants beneficially owned by our executive officers and directors.

Please see the sections titled “Executive Compensation” and “Certain Relationships and Related Transactions, and Director Independence” appearing elsewhere in this Annual Report on Form 10-K for information regarding material relationships with our principal securityholders within the past two years.